235 Spam-Free Article(s) Found
Symbol Name Last Close Mkt Cap DailyStocks'
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Tuesday’s Close
GWPH GW Pharmaceuticals Plc $141.07 $3.98B N/A
Article Searches
The Big Question For GW Pharmaceuticals https://seekingalpha.com/article/4211579-big-question-gw-pharmaceuticals?source=feed_sector_healthcare Oct 15, 2018 - Epidiolex will soon be hitting the shelves.Its success or failure in the market will have huge implications across the pure botanical medical cannabis space.GW Pharmaceuticals has the challenge of con
Dorsey Wright & Associates Buys GW Pharmaceuticals PLC, Icon PLC, AerCap Holdings NV, Sells ... http://www.gurufocus.com/news/752722/dorsey-wright--associates-buys-gw-pharmaceuticals-plc-icon-plc-aercap-holdings-nv-sells-empresa-distribuidora-y-comercializadora-norte-sa-sociedad-quimica-y-minera-de-chile-sa-sodastream-international Oct 12, 2018 - Dorsey Wright & Associates Buys GW Pharmaceuticals PLC, Icon PLC, AerCap Holdings NV, Sells Empresa Distribuidora y Comercializadora Norte SA, Sociedad Quimica Y Minera De Chile SA, SodaStream International, Stocks: BIO,ALGN,NRG,PBF,MA,URBN,GWPH,ICLR,AER,SHPG,TOT,SN, release date:Oct 12, 2018
DavidsTea: Management Is Dumb As A Fox https://seekingalpha.com/article/4211157-davidstea-management-dumb-fox?source=feed_tag_editors_picks Oct 11, 2018 - Conventional wisdom suggests that shares of DavidsTea traded up 63% (On Oct. 2nd) based on speculation, however, there is more to the story.On late September 27th, the DEA moved CBD from its list of S
Top Marijuana Stocks Offering New Opportunities For Investors https://seekingalpha.com/article/4209437-top-marijuana-stocks-offering-new-opportunities-investors?source=feed_all_articles Oct 02, 2018 - Canada is set to flip the switch for legal sale of recreational marijuana in just a few weeks.Marijuana stocks are taking center stage ahead of Canada's legalization so investors should be aware of th
The pot stocks are soaring again after a CBD-based drug took a step closer to commercial launch https://www.cnbc.com/2018/09/27/pot-stocks-tear-higher-after-dea.html Sep 27, 2018 - Pot stocks ripped higher Thursday after the DEA classified a cannabidiol-based drug made by GW Pharmaceuticals in its least restrictive category.
DEA reschedules Epidiolex, marijuana-derived drug, paving the way for it to hit the market https://www.cnbc.com/2018/09/27/dea-schedules-epidiolex-allowing-gw-pharma-to-start-selling-the-drug.html Sep 27, 2018 - This paves the way for GW Pharmaceuticals to start selling the first FDA-approved drug that's derived from cannabis, but the DEA stopped short of reclassifying all cannabidiol products.
Marijuana Stocks Soar Again As Wall Street Eyes U.S. Imports http://www.zacks.com/stock/news/323901/marijuana-stocks-soar-again-as-wall-street-eyes-us-imports?cid=CS-ZC-FT-323901 Sep 19, 2018 - Shares of several popular Canadian marijuana producers--including Tilray (TLRY), Canopy Growth (CGC), and Cronos Group (CRON)--were surging once again on Wednesday as Wall Street grows ever-more bullish on the prospects of legalization and U.S. imports.
Canadian marijuana producer Tilray paused by exchange due to volatility amid 70% surge https://www.cnbc.com/2018/09/19/marijuana-producer-tilray-up-another-40percent-as-cannabis-stocks-blossom.html Sep 19, 2018 - Tilray CEO Brendan Kennedy told CNBC that pharmaceutical companies must start thinking about partnering with cannabis producers as a "hedge" against the space.
ETFs & Stocks to Tap Marijuana Boom http://www.zacks.com/stock/news/322978/etfs-stocks-to-tap-marijuana-boom?cid=CS-ZC-FT-322978 Sep 13, 2018 - Investors seeking to tap the ongoing green rush may consider these ETFs and stocks.
Two Superstars Join Forces https://seekingalpha.com/article/4206010-two-superstars-join-forces?source=feed_all_articles Sep 13, 2018 - Marijuana has the potential to take share away from domestic brewers.If you can’t beat them, join them.And if you’re going to form a strategic partnership, you might as well do it with a market leader

Pages: 123456...24

Page 1>

Related Companies

Name Exchange Price Mkt Cap
TARO Taro Pharmaceutical Industries Ltd. NYSE $99.5 $3.92B
RARE Ultragenyx Pharmaceutical Inc. NASDAQ $82.475 $4.14B
AGIO Agios Pharmaceuticals, Inc. NASDAQ $71.9 $4.17B
HCM Hutchison China MediTech Limited NASDAQ $28.45 $3.79B
ENDP Endo International plc NASDAQ $15.85 $3.55B
Sector: Health Care > Industry: Major Pharmaceuticals
DeepLinks for GW Pharmaceuticals Plc